Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGE-117 for Anemia of Aging
NCT04815603Phase 2Withdrawn
- Sponsor
- BioAge Labs
- Start
- Mar 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TS-143 in anemia, sponsored by BioAge Labs. Planned start Mar 2021; status: withdrawn.
02
Drugs
TS-143
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04815603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815603.